Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab. Academic Article uri icon

Overview

publication date

  • October 5, 2023

Research

keywords

  • Hodgkin Disease
  • Lymphoma, Non-Hodgkin

Identity

Digital Object Identifier (DOI)

  • 10.1080/10428194.2023.2262641

PubMed ID

  • 37794809